1980
DOI: 10.1056/nejm198009253031306
|View full text |Cite
|
Sign up to set email alerts
|

Familial Neonatal Transient Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
102
3
2

Year Published

1986
1986
2012
2012

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 310 publications
(110 citation statements)
references
References 12 publications
3
102
3
2
Order By: Relevance
“…When the TSH-receptor stimulating antibodies cross the placenta they can cause neonatal thyrotoxicosis (Munro, et al, 1978, Matsuura, et al, 1988, Tamaki, et al, 1988a while TSH-receptor blocking antibodies can cause neonatal transient hypothyroidism (Matsuura, et al, 1980). However, the relation between the titer of mother's TSH-receptor antibody and the status of the offspring has not been fully elucidated.…”
mentioning
confidence: 99%
“…When the TSH-receptor stimulating antibodies cross the placenta they can cause neonatal thyrotoxicosis (Munro, et al, 1978, Matsuura, et al, 1988, Tamaki, et al, 1988a while TSH-receptor blocking antibodies can cause neonatal transient hypothyroidism (Matsuura, et al, 1980). However, the relation between the titer of mother's TSH-receptor antibody and the status of the offspring has not been fully elucidated.…”
mentioning
confidence: 99%
“…These blocking antibodies (TSBAbs) compete with TSH for receptor binding and block the biological effects of TSH on thyroid cells, including cAMP production, iodine uptake, and thyroid cell growth (26)(27)(28). They induce transient neonatal hypothyroidism when transferred across the placenta (29,30). TSBAb assay quantitates inhibition by autoantibodies of the increase in cAMP production or the iodide uptake in response to a standard concentration of TSH in the FRTL-5 cell (26)(27)(28) or CHO-TSHR cell (31,32).…”
Section: Thyroid Stimulation Blocking Antibody Assaymentioning
confidence: 99%
“…Mother with grave's disease may have transplacental passage of medications (methimazole, propylthiouracil), TSH blocking antibodies [18,19] and maternal iodine deficiency may contribute to this form of CH. It is often difficult to distinguish newborns with transient CH from those with permanent CH, maternal TSH antibodies may be in the newborn's circulation for several weeks to months [20].…”
Section: Introductionmentioning
confidence: 99%